# EDGAR Filing Document

**Accession Number:** 0001953988
**File Stem:** 0001213900-25-090124
**Filing Date:** 2025-9
**Character Count:** 130008
**Document Hash:** 1ba94d1a54dc37377750d91e589e55fd
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-090124.hdr.sgml**: 20250922

**ACCESSION NUMBER**: 0001213900-25-090124

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 72

**CONFORMED PERIOD OF REPORT**: 20250731

**FILED AS OF DATE**: 20250922

**DATE AS OF CHANGE**: 20250922

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Helio Corp /FL/
- **CENTRAL INDEX KEY:** 0001953988
- **STANDARD INDUSTRIAL CLASSIFICATION:** GUIDED MISSILES & SPACE VEHICLES & PARTS [3760]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 920286004
- **STATE OF INCORPORATION:** FL
- **FISCAL YEAR END:** 1031

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-56774
- **FILM NUMBER:** 251330345

**BUSINESS ADDRESS:**
- **STREET 1:** 2448 SIXTH STREET
- **CITY:** BERKELEY
- **STATE:** CA
- **ZIP:** 94710
- **BUSINESS PHONE:** 510-545-2666

**MAIL ADDRESS:**
- **STREET 1:** 2448 SIXTH STREET
- **CITY:** BERKELEY
- **STATE:** CA
- **ZIP:** 94710

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** WEB3 Corp
- **DATE OF NAME CHANGE:** 20230621

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Stirling Bridge Group Inc
- **DATE OF NAME CHANGE:** 20221109

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, DC 20549**

**FORM 10-Q**

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended **July 31, 2025**

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ______ TO ______

Commission file number: **000-56744**

**HELIO CORPORATION**

(Name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Florida** | **92-0586004** |
| (State or other jurisdiction of<br> incorporation or organization) | (I.R.S. Employer<br> Identification Number) |

---

**2448 Sixth Street Berkeley, CA 94710**

(Address of principal executive offices including zip code)

**(510) 545-2666**

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act: **None**

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act

(Check one):

☐ Large accelerated Filer ☐ Accelerated Filer <br> ☒ Non-accelerated Filer ☒ Smaller reporting company <br> ☒ Emerging Growth Company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of September 22, 2025, there were 11,371,966 shares of the registrant's common stock, no par value per share, outstanding.

**Table of Contents**

---

| | |
|:---|:---|
| [PART I—FINANCIAL INFORMATION](#a_001) | 1 |
| &nbsp;&nbsp;&nbsp;[Item 1. Financial Statements](#a_002) | 1 |
| &nbsp;&nbsp;&nbsp;[Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](#a_008) | 2 |
| &nbsp;&nbsp;&nbsp;[Item 3. Quantitative and Qualitative Disclosures About Market Risk](#a_009) | 13 |
| &nbsp;&nbsp;&nbsp;[Item 4. Controls and Procedures](#a_010) | 13 |
| [PART II—OTHER INFORMATION](#a_011) | 15 |
| &nbsp;&nbsp;&nbsp;[Item 1. Legal Proceedings](#a_012) | 15 |
| &nbsp;&nbsp;&nbsp;[Item 1A. Risk Factors](#a_013) | 15 |
| &nbsp;&nbsp;&nbsp;[Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](#a_014) | 15 |
| &nbsp;&nbsp;&nbsp;[Item 4. Mine Safety Disclosures](#a_015) | 15 |
| &nbsp;&nbsp;&nbsp;[Item 5. Other Information](#a_016) | 15 |
| &nbsp;&nbsp;&nbsp;[Item 6. Exhibits](#a_017) | 16 |
| [SIGNATURES](#a_018) | 17 |

---

PART I—FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

The following unaudited interim condensed consolidated financial statements of Helio Corporation (referred to herein as the "Company,") are included in this Quarterly Report on Form 10-Q (the "Quarterly Report").

The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States and the rules of the Securities and Exchange Commission (the "SEC"), In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the periods presented have been reflected herein. The results of operations for the periods presented are not necessarily indicative of the results to be expected for the full year.

**Helio Corporation**

**Financial Statements for the Three and Nine Months Ended July 31, 2025**

**Index to the Condensed Consolidated Financial Statements (Unaudited)**

---

| | |
|:---|:---|
|  | **Page No.** |
| [Condensed Consolidated Balance Sheets at July 31, 2025 (Unaudited) and October 31, 2024](#a_003) | F-2 |
| [Condensed Consolidated Statements of Operations for the three and nine months ended July 31, 2025 and 2024 (Unaudited)](#a_004) | F-3 |
| [Condensed Consolidated Statements of Changes in Shareholders' Deficit for the three and nine months ended July 31, 2025 and 2024 (Unaudited)](#a_005) | F-4 |
| [Condensed Consolidated Statements of Cash Flows for the nine months ended July 31, 2025 and 2024 (Unaudited)](#a_006) | F-5 |
| [Notes to Condensed Consolidated Financial Statements (Unaudited)](#a_007) | F-6 |

---

**HELIO CORPORATION**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

---

| | | |
|:---|:---|:---|
|  | **July 31,**<br>**2025** | **October 31,**<br>**2024** |
|  | (unaudited) | (audited) |
| **Assets** |  |  |
| Current Assets: |  |  |
| Cash | $43933 | $551552 |
| Accounts receivable, net | 601333 | 1390202 |
| Work in progress | 168681 | 343218 |
| Prepaid expenses and other current assets | 29928 | - |
| Total Current Assets | 843875 | 2284972 |
| Property and equipment, net | 70393 | 87389 |
| Security deposits | 76655 | 76655 |
| Right-of-use assets, net | 659320 | 959377 |
| Total Non-current Assets | 806368 | 1123421 |
| **TOTAL ASSETS** | $1650243 | $3408393 |
| **Liabilities and Shareholders' Deficit** |  |  |
| LIABILITIES |  |  |
| Current Liabilities: |  |  |
| Accounts payable and accrued expenses | $199560 | $140439 |
| Accrued compensation | 1012192 | 805405 |
| Notes Payable - Related Parties | 668280 | 420000 |
| Notes payable | 1681731 | 200000 |
| Operating lease obligations, current | 121922 | 503124 |
| Total Current Liabilities | 3683685 | 2068968 |
| Notes payable - Related Parties, less current portion | 495000 | 182877 |
| Notes payable, less current portion | 150000 | 1150000 |
| Operating lease obligations | 682059 | 608723 |
| Total Non-current Liabilities | 1327059 | 1941600 |
| **Total Liabilities** | 5010744 | 4010568 |
| Commitments and contingencies (Note 8) |  |  |
| **Shareholders' Deficit** |  |  |
| Common stock, no par value, 44,000,000 shares authorized; 11,263,633 shares issued and outstanding as of July 31, 2025 and October 31, 2024, respectively | 466464 | 339861 |
| Accumulated deficit | (3826965) | (942036) |
| **Total Shareholders' Deficit** | (3360501) | (602175) |
| **Total Liabilities and Shareholders' Deficit** | $1650243 | $3408393 |

---

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

**HELIO CORPORATION**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the Three Months Ended** | **For the Three Months Ended** | **For the Nine Months Ended** | **For the Nine Months Ended** |
|  | **July 31,**<br>**2025** | **July 31,**<br>**2024** | **July 31,**<br>**2025** | **July 31,**<br>**2024** |
| **Revenue:** |  |  |  |  |
| Service fees | $508913 | $639239 | $2104275 | $2221509 |
| Engineering fees | 40234 | 274625 | 289587 | 824495 |
| Materials | 235440 | 750329 | 990561 | 2290372 |
| **Total Revenue** | 784587 | 1664193 | 3384423 | 5336376 |
| Costs of revenue | 686197 | 1103485 | 2680940 | 3389439 |
| **Gross profit** | 98390 | 560708 | 703483 | 1946937 |
| **Operating expenses** |  |  |  |  |
| General and administrative expenses | 607537 | 502215 | 2072456 | 2097506 |
| Personnel expenses | 116664 | 127336 | 408908 | 336727 |
| Facilities expense | 49722 | 115728 | 249480 | 332798 |
| Professional fees | 120676 | 60000 | 343495 | 206903 |
| Depreciation expense | 5666 | 5666 | 16996 | 16996 |
| Right of use amortization | 100019 | 100019 | 300057 | 270247 |
| Total Operating Expenses | 1000284 | 910964 | 3391392 | 3261177 |
| **Operating loss** | (901894) | (350256) | (2687909) | (1314240) |
| **Other expense:** |  |  |  |  |
| Interest expense, net | (48860) | (24430) | (197020) | (55559) |
| Total other expense | (48860) | (24430) | (197020) | (55559) |
| Provision for income taxes | - | - | - | - |
| **Net loss** | $(950754) | $(374686) | $(2884929) | $(1369799) |
| **Basic and diluted net loss per share** | $(0.08) | $(0.03) | $(0.26) | $(0.12) |
| **Weighted average shares outstanding – basic and diluted** | 11263633 | 11263633 | 11263633 | 11263633 |

---

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

**HELIO CORPORATION**

**CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' (DEFICIT) EQUITY**

**(UNAUDITED)**

**FOR THE THREE AND NINE MONTHS ENDED JULY 31, 2025 AND 2024**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **No par-value <br> Common Stock** | **No par-value <br> Common Stock** | | |
|  | **Shares** | **Amount** | **Accumulated**<br>**Deficit** |<br>**Totals** |
| **Balances as of October 31, 2023 (as previously reported)** | 16000000 | $33256 | $920647 | $953903 |
| &nbsp;&nbsp;&nbsp;Conversion of shares due to recapitalization\* | (4736367) | 81818 | - | 81818 |
| **Balances at October 31, 2023, effect of recapitalization** | 11263633 | 115074 | 920647 | 1035721 |
| &nbsp;&nbsp;&nbsp;Stock-based compensation |  | 21154 | - | 21154 |
| &nbsp;&nbsp;&nbsp;Net loss | - | - | (241726) | (241726) |
| **Balances at January 31, 2024** | 11263633 | 136228 | 678921 | 815149 |
| &nbsp;&nbsp;&nbsp;Stock-based compensation |  | 61767 | - | 61767 |
| &nbsp;&nbsp;&nbsp;Net loss | - | - | (753388) | (753388) |
| **Balances at April 30, 2024** | 11263633 | 197995 | (74467) | 123528 |
| &nbsp;&nbsp;&nbsp;Stock-based compensation |  | 56600 | - | 56600 |
| &nbsp;&nbsp;&nbsp;Net loss | - | - | (374686) | (374686) |
| **Balances at July 31, 2024** | 11263633 | $254595 | $(449153) | $(194558) |
| **Balances at October 31, 2024** | 11263633 | $339861 | $(942036) | $(602175) |
| &nbsp;&nbsp;&nbsp;Stock-based compensation |  | 46497 | - | 46497 |
| &nbsp;&nbsp;&nbsp;Net loss | - | - | (919142) | (919142) |
| **Balances at January 31, 2025** | 11263633 | 386358 | (1861178) | (1474820) |
| &nbsp;&nbsp;&nbsp;Stock-based compensation |  | 41257 | - | 41257 |
| &nbsp;&nbsp;&nbsp;Net loss | - | - | (1015033) | (1015033) |
| **Balances at April 30, 2025** | 11263633 | 427615 | (2876211) | (2448596) |
| &nbsp;&nbsp;&nbsp;Stock-based compensation |  | 38849 | - | 38849 |
| &nbsp;&nbsp;&nbsp;Net loss | - | - | (950754) | (950754) |
| **Balances at July 31, 2025** | 11263633 | $466464 | $(3826965) | $(3360501) |

---

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

**HELIO CORPORATION**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(UNAUDITED)**

---

| | | |
|:---|:---|:---|
|  | **For the Nine Months Ended <br> July 31,** | **For the Nine Months Ended <br> July 31,** |
|  | **2025** | **2024** |
| **CASH FLOWS USED IN OPERATING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;Net loss | $(2884929) | $(1369799) |
| &nbsp;&nbsp;&nbsp;Adjustments to reconcile net loss to net cash (used in) operating activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 16996 | 16996 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 126603 | 139521 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Right of use asset amortization | 300057 | 270247 |
| &nbsp;&nbsp;&nbsp;Changes in assets and liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | 788869 | 992014 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | (29928) | 799 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Work in progress | 174537 | (958445) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | 59121 | (305565) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued compensation | 206787 | 172810 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease obligations | (307866) | (243655) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash (used in) operating activities** | (1549753) | (1285077) |
| **CASH FLOWS FROM FINANCING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from notes payable | 550000 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from notes payable - related parties | 560403 | 1046306 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayment of notes payable - related parties | (68269) | (13852) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Recapitalization | - | 81818 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash provided by financing activities** | 1042134 | 1114272 |
| **NET DECREASE IN CASH** | (507619) | (170805) |
| **CASH - BEGINNING OF PERIOD** | 551552 | 504335 |
| **CASH - END OF PERIOD** | $43933 | $333531 |
| **CASH PAID DURING THE PERIOD FOR:** |  |  |
| &nbsp;&nbsp;&nbsp;Interest expense | $127542 | $2157 |
| &nbsp;&nbsp;&nbsp;Income taxes | $- | $- |

---

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

**HELIO CORPORATION**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**July 31, 2025**

**(UNAUDITED)**

**NOTE 1: BUSINESS**

Helio Corporation (the "Company" or "Helio") is an aerospace technology, engineering, and research and development (R&D) holding company serving commercial, government, and non-profit organizations. Heliospace Corporation ("Heliospace"), the Company's wholly-owned subsidiary, is an aerospace company specializing in the design, engineering, assembly and test of space flight qualified hardware, providing systems engineering, modeling, analysis, integration and test services for space missions. Heliospace was incorporated on March 6, 2018 in Delaware. The Company's products include aerospace related hardware, systems, and services for customers such as NASA, universities, and private space companies. The customer base ranges from NASA and foreign space agencies to private companies, foundations, universities, and non-profits.

Heliospace designs, fabricates, assembles and tests space qualified hardware, including radar antennas for the NASA Europa Clipper mission, antennas for the SunRISE CubeSat constellation, and deployable systems and sensors for numerous lunar landers and the Mars Sample Return program. Heliospace also provides systems engineering, integration and test, and mission formulation services, including support for the design, testing, and launch of the James Webb Space Telescope, formulation and design of the Roman Space Telescope, Habworlds Observatory, Mars Sample Return, and the Atmospheric Observing System.

 

*Change-in-control Transaction*

On October 3, 2022, Helio was incorporated in Florida, under the name Stirling Bridge Group, Inc. In October of 2023, the Company changed its name to Web3 Corporation. In January 2024, the Company acquired 100% of Heliospace's common stock shares in exchange for 9,975,733 newly issued Common Stock Shares of the Company (the "Share Exchange"), and changed its name from Web3 Corporation to the Helio Corporation. The Company's principal executive offices are located at 2448 Sixth Street, Berkeley, CA 94710. The transaction was accounted for as a recapitalization of Heliospace as Heliospace was deemed the accounting acquirer. The historical financial statements are that of Heliospace; therefore the pre-transaction financial statements are that of Heliospace. The transaction was effective on January 4, 2024 and combines the financial statements from the transaction date forward.

***Liquidity***

The Company has historically funded its working capital, research and development and capital expenditure requirements and other commitments (including debt service and repayment) from its operating cash flows, debt financing, and issuances of equity. The Company has historically experienced negative cash flows from operations and recurring net losses.

In May and June 2025, the Company entered into an additional note payable agreement and a Receivables Sale Agreement to obtain additional funding (see Note 5). Additional financing or capital investment will be necessary to sustain operations for one year from the issuance of these condensed consolidated financial statements.

The Company is currently engaged in negotiations with prospective lenders regarding potential bridge financing arrangements, and potential investors for the purchase of convertible notes or equity investments. These discussions are ongoing, and there can be no assurance that the Company will enter into definitive agreements or that any such financing will be completed on favorable terms or at all.

If completed, the Company expects to use the net proceeds from investments and bridge financing to repay certain outstanding promissory notes and to support key operational initiatives. These include investments in research and development, expansion of sales, marketing, and business development activities, facility and infrastructure enhancements, manufacturing improvements, and other general corporate purposes, including working capital and upgrades to the Company's financial and contract management systems.

The Company will need to raise substantial additional capital to accomplish its business plan for the foreseeable future. There can be no assurance as to the availability, if any, or terms upon which such financing and capital might be available in the future. As of July 31, 2025, the Company had cash and cash equivalents of $43,933, a decrease of $507,619 from $551,552 as of October 31, 2024.

The Company has outstanding unsecured notes to certain related parties with an aggregate outstanding principal balance of $1,163,280 as of July 31, 2025, the proceeds of which were used to meet working capital and cash flow management needs. The notes bear interest at between 6.5% and 11.25% per annum. $668,280 of these notes mature in the current 2025 fiscal year, and the remaining $495,000 mature in the 2026, 2027, or 2028 fiscal years.

As of July 31, 2025, the Company has outstanding debt from unrelated parties pursuant to notes payable in the aggregate principal amount of $1,831,731. These notes bear interest at 9.75% and 12.00% and mature within the next two fiscal years. Certain of these notes were initially convertible but were amended to eliminate the conversion features in consideration of the issuance by the Company and/or the transfer by certain shareholders of shares of the Company's common stock (See Note 5). Interest on these notes either accrues or is paid quarterly or at maturity along with principal, as specifically described in the note. Upon the occurrence and during the continuance of any default by the Company under any of the above notes, which default is not cured within fifteen (15) days following written notice of such default from the payee, the payee may declare the entire unpaid principal and unpaid interest immediately due and payable. Certain of these notes are secured by the Company's accounts receivable, and by shares of common stock pledged by one of the Company's shareholders. In addition, certain of these notes become due, and the payees under certain of these notes have the right to accelerate their notes, upon the completion of an offering.

Because of historical and expected operating losses and net operating cash flow deficits, there is substantial doubt about the Company's ability to continue as a going concern for one year from the issuance of the unaudited condensed consolidated financial statements. The unaudited condensed consolidated financial statements have been prepared under the going concern basis of accounting. These unaudited condensed consolidated financial statements do not include any adjustments that might be necessary from the outcome of this uncertainty.

**NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

***Basis of Presentation and Consolidation***

 ****

The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to U.S. generally accepted accounting principles ("U.S. GAAP) and reflect all adjustments which are, in the opinion of management, necessary to a fair presentation of the results of the interim periods presented, under the rules and regulations of the United States Securities and Exchange Commission (the "SEC"). These unaudited condensed consolidated financial statements include all adjustments consisting of only normal recurring adjustments, necessary for a fair statement of the results of the interim periods presented. The unaudited condensed consolidated financial statements include the accounts of Helio Corporation and its wholly-owned subsidiary Heliospace. The Company's unaudited condensed consolidated financial statements reflect the elimination of all significant inter-company accounts and transactions. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for any subsequent quarter or for the entire year ending October 31, 2025. Certain information and note disclosures normally included in the Company's annual audited consolidated financial statements and accompanying notes prepared in accordance with U.S. GAAP have been condensed in, or omitted from, these interim financial statements. Accordingly, these unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes to the consolidated financial statements for the fiscal year ended October 31, 2024 included in the Company's financial statements included in Form S-1/A filed with the SEC on March 7, 2025.

***Reclassification***

In the preparation of the unaudited condensed consolidated financial statements, the Company identified a $50,000 amount previously classified as Notes payable was more appropriately classified as Notes payable – related parties within the consolidated balance sheet as of October 31, 2024. Upon evaluation, the Company determined that the impact of this reclassification was immaterial to the consolidated financial statements taken as a whole. The reclassification is reflected within the October 31, 2024 balances presented in the accompanying unaudited condensed consolidated balance sheets, and was made to enhance comparability and transparency of the financial statements. For the three and nine months ended July 31, 2024 period, the Company reclassified certain amounts on the statements of operations from facilities expense to right of use amortization to correctly reflect the amortization.

 ****

***Cash and Cash Equivalents***

For the purposes of the unaudited condensed consolidated statements of cash flows, the Company considers all highly liquid investments purchased with a maturity of three (3) months or less to be cash equivalents. The Company has no cash equivalents as of July 31, 2025 and October 31, 2024.

Cash accounts are insured at the Federal Deposit Insurance Corporation limits of $250,000 per bank. At times throughout the year, such bank balances may have exceeded the federally insured limit. As of July 31, 2025, there were no bank balances in excess of the federally insured limit.

 ****

***Work In Progress***

Work In Progress (WIP) tracks the costs incurred of a specific job that has not reached a certain milestone achievement. This is the computed value of work performed to advance milestone(s) that have not yet been billed and is used to track total job cost (billed and unbilled). Revenue of WIP is only recognized for specific milestones that are distinct contractual performance obligations that provide identifiable benefits to the customer independently of other project phases.

 ****

***Accounts Receivable, net***

Accounts receivables are recorded at the amount the Company expects to collect on the balance outstanding at period-end. Management closely monitors outstanding balances during the year and allocates an allowance account if appropriate. The Company estimates and records a provision for its expected credit losses related to its financial instruments, including its trade receivables and contract assets. The Company considers historical collection rates, the current financial status of its customers, macroeconomic factors, and other industry-specific factors when evaluating for current expected credit losses. Forward-looking information is also considered in the evaluation of current expected credit losses. However, because of the short time to the expected receipt of accounts receivable, the Company believes that the carrying value, net of expected losses, approximates fair value and therefore, relies more on historical and current analysis of such financial instruments. Based on this analysis, the Company has determined that no allowance for credit losses is necessary for the current or prior reporting periods.

As of July 31, 2025 and October 31, 2024, there was no amount recorded relating to the allowance for credit losses. The Company writes off bad debts as they occur during the year, if applicable. Accounts receivable as of July 31, 2025 and October 31, 2024 was $601,333 and $1,390,202.

***Property and Equipment, net***

Property and equipment is stated at cost. Depreciation is computed primarily using the straight-line method over the estimated useful lives of the assets. Expenditures for repairs and maintenance are charged to expense as incurred. For assets sold or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts, and any related gain or loss is reflected in the unaudited condensed consolidated statements of operations during the period in which the disposal occurred. The Company computes depreciation utilizing estimated useful lives, as stated below:

---

| | |
|:---|:---|
| **Property and Equipment, net Categories** | **Estimated<br> Useful Life** |
| Furniture and equipment | 10 Years |

---

Management regularly reviews property and equipment for possible impairment. This review occurs annually or more frequently if events or changes in circumstances indicate the carrying amount of the asset may not be recoverable. Based on management's assessment, there were no indicators of impairment of the Company's property and equipment as of July 31, 2025 or October 31, 2024, respectively.

 ****

***Use of Estimates***

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.

 ****

***Fair Value Measurements***

Accounting Standards Codification ("ASC") 820 *Fair Value Measurements* defines fair value, establishes a framework for measuring fair value in U.S. GAAP and expands disclosure about fair value measurements.

The following provides an analysis of financial instruments that are measured subsequent to initial recognition at fair value, grouped into Levels 1 to 3 based on the degree to which fair value is observable:

---

| | |
|:---|:---|
| Level 1 — | fair value measurements are those derived from quoted prices (unadjusted in active markets for identical assets or liabilities); |
| Level 2 — | fair value measurements are those derived from inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices); and |
| Level 3 — | fair value measurements are those derived from valuation techniques that include inputs for the asset or liability that are not based on observable market data (unobservable inputs). |

---

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management for the respective periods. The respective carrying value of certain financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash, short-term notes payable, accounts payable and accrued expenses. The carrying value of long-term debt approximates fair value, as the variable interest rates approximate current market rates.

 ****

***Revenue Recognition***

The Company records revenue based on a five-step model in accordance with the Financial Accounting Standards Board ("FASB") ASC 606, *Revenue from Contracts with Customers*, which requires the following:

&nbsp;&nbsp;&nbsp;&nbsp;1. Identify
the contract with a customer.

&nbsp;&nbsp;&nbsp;&nbsp;2. Identify
the performance obligations in the contract.

&nbsp;&nbsp;&nbsp;&nbsp;3. Determine
the transaction price of the contract.

&nbsp;&nbsp;&nbsp;&nbsp;4. Allocate
the transaction price to the performance obligations in the contract.

&nbsp;&nbsp;&nbsp;&nbsp;5. Recognize
revenue when the performance obligations are met or delivered.

The Company's operating revenues are primarily generated from service fees, engineering fees, and materials fees. The Company uses two different types of contracts which are deliverable based or time based. The Company recognizes revenue related to services when performance obligations are fulfilled.

Design service contracts deliver system engineering inputs including designs, analyses, test and verification plans, and mission formulation architectures on a continual basis over the course of a contract. Customer work is based on distinct identifiable contracts with clear performance obligations, objectives, and pricing. Service revenue contract types are either Time & Materials (T&M) or Purchase Order (PO) contracts. Time & Materials contracts meet performance obligations continuously and are billed with revenue recognized at each invoice. PO contracts are billed at fulfillment of a performance obligation based on the customer agreements, and thus revenue is recognized when earned.

Engineering services deliver both space qualified hardware and accompanying analyses, and are conducted under Cost-type, Fixed price, PO, and T&M contracts. Cost-type and T&M Engineering contracts are billed monthly as work is completed and revenue is recognized. Revenue for fixed price contracts including purchase orders that specify priced milestones for delivery of hardware, reports, or analyses is recognized upon completion of a specific milestone. Revenue on fixed price contracts that are still in progress at month end are otherwise recognized on the percentage-of-completion method, measured by the percentage of total costs incurred to date to the estimated total costs for each contract.

***Income Taxes***

The Company accounts for income taxes under the provisions of ASC 740 *Accounting for Income Taxes,* which requires a company to first determine whether it is more likely than not (which is defined as a likelihood of more than fifty percent) that a tax position will be sustained based on its technical merits as of the reporting date, assuming that taxing authorities will examine the position and have full knowledge of all relevant information. A tax position that meets this more likely than not threshold is then measured and recognized at the largest amount of benefit that is greater than fifty percent likely to be realized upon effective settlement with a taxing authority.

Deferred income taxes are recognized for the tax consequences related to temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for tax purposes at each year end, based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Deferred income taxes are also recognized for carry-forward losses which can be utilized to offset future taxable income. A valuation allowance is recognized when, based on the weight of all available evidence, it is considered more likely than not that all, or some portion, of the net deferred tax assets will not be realized. The Company evaluates its valuation allowance requirements based on projected future operations. When circumstances change and cause a change in management's judgment about the recoverability of deferred tax assets, the impact of the change on the valuation is reflected in current income. Income tax expense is comprised of the sum of current income tax plus the change in deferred tax assets and liabilities.

 ****

***Earnings (loss) Per Share***

Basic net (loss) income per common share is computed by dividing net (loss) income by the weighted average number of vested common shares outstanding during the period. Diluted net (loss) income per common share is computed by dividing net (loss) income by the weighted average number of outstanding common shares, plus the net impact of common shares (computed using the treasury stock method), if dilutive, resulting from the exercise of dilutive securities. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents because their inclusion would be anti-dilutive. As of July 31, 2025 and 2024, the Company excluded the common stock equivalents summarized below, which entitle the holders thereof to ultimately acquire shares of common stock, from its calculation of earnings per share, as their effect would have been anti-dilutive.

---

| | | |
|:---|:---|:---|
|  | **July 31,** | **July 31,** |
|  | **2025** | **2024** |
| **Stock options** | 1422307 | 1422307 |
| **Total common stock equivalents** | 1422307 | 1422307 |

---

***Leases***

The Company accounts for leases based on ASC Topic 842, *Leases.* Based on this standard, the Company determines if an agreement is a lease at inception. Operating leases are included in right-of-use asset, current operating lease obligations, and operating lease obligations, in the Company's unaudited condensed consolidated balance sheets. Finance leases are included in property and equipment, net, current portion of long-term debt, net and long-term debt, less current portion, and debt issuance costs in the Company's unaudited condensed consolidated balance sheets.

 ****

As permitted under ASU 2016-02 *Leases* (Topic 842) the Company has made an accounting policy election not to apply the recognition provisions of ASU 2016-02 to short term leases (leases with a lease term 12 months or less that do not include an option to purchase the underlying asset that the lessee is reasonably certain to exercise); instead, the Company will recognize the lease payments for short term leases on a straight-line basis over the lease term.

 **

***Research and Development***

 **

Research and development costs are expensed as incurred. These costs include, but are not limited to, employee related expenses, including salaries, benefits and stock-based compensation of research and development personnel, supplies; facilities, depreciation and other expenses, which include direct and allocated expenses for rent, utilities and insurance.

 ****

***Stock based-Based Compensation***

The Company accounts for equity instruments issued to employees in accordance with the provisions of ASC 718, *Stock Compensation*. The computation of the expense associated with stock-based compensation requires the use of a valuation model. The Company currently obtains valuation reports according to FASB ASC Topic 718 — *Stock Compensation* ("ASC 718"). Equity-based compensation consists solely of stock option awards, including Incentivized Stock Options (ISOs) and Non-Qualified Stock Options (NSOs), whose exercise prices are determined by the 409A valuation reports. Compensation expense is recognized ratably over the vesting period as the employee provides services. See Note 6 – Stock Options for additional information.

 ***Benefit Plan***

The Company offers a 401(k) plan. Employees are eligible to participate in the plan on the first day of the month following the date of hire. Employees may defer up to $23,500 for 2025 and $23,000 for 2024. The Company is required to contribute on behalf of each eligible participating employee. The Company will match 100% of the participants deferral not to exceed 4% of employee compensation. Employees will share in the matching contribution regardless of the amount of service completed during the plan year. Employees will become 100% vested in the employer matching contributions after six years of service. In the three and nine months ended July 31, 2024, benefit contributions were $49,895 and $92,546, respectively. In the three and nine months ended July 31, 2025, benefit contributions were $43,285 and $91,304, respectively. Benefit contributions are included within general and administrative expenses in the condensed consolidated statements of operations.

***Subsequent Events***

The Company evaluates events and transactions that occur after the condensed consolidated balance sheet date through the date the unaudited condensed consolidated financial statements are issued or available for issuance, to determine whether they should be recognized or disclosed in the unaudited condensed consolidated financial statements.

 ****

***Recently Issued Accounting Pronouncements***

Recent accounting pronouncements that the Company has adopted or that will be required to adopt in the future are summarized below.

In November 2023, the FASB issued ASU No. 2023-07, *Segment Reporting* (Topic 280): *Improvements to Reportable Segment Disclosures*. This standard requires a public entity to disclose significant segment expenses and other segment items on an interim and annual basis. Additionally, it requires a public entity to disclose the title and position of the Chief Operating Decision Maker ("CODM"). The new standard is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. A public entity should apply the amendments in this ASU retrospectively to all prior periods presented in the financial statements. The Company adopted this ASU in November 1, 2024. The adoption of this ASU had no effect on the Company's results of operations. See Note 11 for the required disclosures associated with this update.

The Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

**NOTE 3: PROPERTY AND EQUIPMENT**

The major classifications of property and equipment are summarized as follows:

---

| | | |
|:---|:---|:---|
|  | **July 31, 2025** | **October 31, 2024** |
| Property and equipment | $465091 | $465091 |
| Less accumulated depreciation | (394698) | (377702) |
| Property and equipment, net | $70393 | $87389 |

---

Depreciation expense for each of the three months ended July 31, 2025 and 2024 was $5,666. Depreciation expense for each of the nine months ended July 31, 2025 and 2024 was $16,996.

**NOTE 4: NOTES PAYABLE – RELATED PARTIES**

Between April 2022 and February 2025, certain related parties, including the Company's Chief Executive Officer and Director and its Chief Engineer and Director, made various loans to the Company. The balance at July 31, 2025 and October 31, 2024 was $1,163,281 and $602,877, respectively. The loans' terms are between 5 and 36 months and are classified as current and non-current liabilities on the unaudited condensed consolidated balance sheets with 6.50% to 11.25% interest per annum. All unpaid principal, accrued interest, and other amounts owing under the above notes are paid at maturity. These notes are collateralized with the Company receivables and other assets.

Included within the notes payable – related parties balance is a convertible note agreement entered on March 18, 2024 for $50,000. The convertible note was scheduled to mature on March 18, 2026 and carries an interest rate of 9.75% per annum. The principal and prior accrued interest of the note was convertible into shares of the Company's common stock at $2.00 per share. On October 31, 2024, the Company amended the agreement with the holder of the note to change its maturity to the earlier of the date that the Company lists its securities on a national stock exchange or March 31, 2025 and eliminated the conversion feature of the note. Interest on the note accrues and is paid at maturity along with principal, as specifically described in the note. Interest on the note accrues and is paid at maturity along with principal, as specifically described in the note. The loan incurred interest expense of $1,229 and $3,666 for the three and nine months ended July 31, 2025. Accrued interest as of July 31, 2025 and October 31, 2024 is $3,869 and $203, respectively, which was accrued on the unaudited condensed consolidated balance sheet within the Accounts payable and accrued expenses line item.

On April 25, 2025, the Company executed an extension of the maturity date until the earlier of the date the Company is able to achieve a listing on a national stock exchange or June 30, 2025. The terms of the amended note were not substantially different than the original and therefore did not result in an extinguishment of the original note. On September 22, 2025 the Company executed an extension of the maturity date until the earlier of the date the Company is able to achieve a listing on a national stock exchange or October 31st, 2025, with repayment of the note to occur in monthly installments from October 31<sup>st</sup> through December 31<sup>st</sup> 2025. Under the terms of the extension the note was not considered in default. The terms of the amended note were not substantially different than the original and therefore did not result in an extinguishment of the original note.

On April 16, 2025, the Company issued an unsecured promissory note in the principal amount of $150,000 to Indicia Capital, LLC. The note bears interest at a rate of 9.75% per annum and matures on the earlier of (i) 180 days from the date of issuance or (ii) the date the Company receives at least $1,000,000 in new financing. In connection with the issuance of the note, the Chief Executive Officer and Director transferred 15,000 shares of the Company's common stock to Indicia Capital as additional consideration to enter the loan. James Byrd, who serves as a co-manager and holds a 50% membership interest in Indicia Capital, was the original organizer of the Company by virtue of having founded the Company in October 2022. Accordingly, the transaction is considered a related party transaction. The loan incurred interest expense of $561 and $3,687 for the three and nine months ended July 31, 2025. Accrued interest as of July 31, 2025 is $4,247, which was accrued on the unaudited condensed consolidated balance sheet as of July 31, 2025 within the Accounts payable and accrued expenses line item. On September 22, 2025 the Company executed an extension of the maturity date of the note to October 31<sup>st</sup> 2025, with repayment to occur in monthly installments from October 31st through December 31st 2025. Under the terms of the extension the note was not considered in default. The terms of the amended note were not substantially different than the original and therefore did not result in an extinguishment of the original note.

---

| | | |
|:---|:---|:---|
|  | **July 31, 2025** | **October 31, 2024** |
| Notes payable – related parties, current portion | $668280 | $420000 |
| Notes payable – related parties, non-current portion | 495000 | 182877 |
| Total notes payable – related parties | $1163280 | $602877 |

---

The aggregate maturity on the notes payable – related parties as of July 31, 2025, are as follows:

---

| | |
|:---|:---|
| 2025 | $585404 |
| 2026 | 82876 |
| 2027 | 110000 |
| 2028 | 385000 |
|  | 1163280 |
| Less current portion | (668280) |
| Notes payable – related parties, non-current portion | $495000 |

---

**NOTE 5: NOTES PAYABLE**

On March 12, 2024, the Company executed a note payable agreement for $150,000. The note originally matured on March 12, 2025 and carries an interest rate of 12% per annum. On April 25, 2025, the Company executed an extension of the maturity date until the earlier of the date the Company is able to achieve a listing on a national stock exchange or June 30, 2025. Interest on the note accrues and is paid at maturity along with principal, as specifically described in the note. The loan incurred interest expense of $4,537 and $9,882 for the three and nine months ended July 31, 2025. The loan incurred interest expense of $4,500 and $9,000 for the three and nine months ended July 31, 2024. Accrued interest as of July 31, 2025 and October 31, 2024 is $24,919 and $10,500, respectively, which was accrued on the unaudited condensed consolidated balance sheet within the Accounts payable and accrued expenses line item On September 21, 2025 the Company executed an extension of the maturity date until the earlier of the date the Company is able to achieve a listing on a national stock exchange or November 1<sup>st</sup> 2025, and an acknowledgement that the note was not considered in default.

On June 20, 2024, the Company executed a convertible note payable agreement for $450,000 with a venture capital fund. The convertible note matures on June 20, 2026 and carries an interest rate of 9.75% per annum. The principal and prior accrued interest of the note were convertible into shares of the Company's common stock at $2.00 per share. On October 7, 2024, $50,000 of the note payable was assigned to an unrelated holder. On October 31, 2024, the Company amended the agreement with the holder of the $50,000 note to change its maturity to the earlier of the Company listing on a national stock exchange or March 31, 2025 and eliminated the conversion feature of the note. On October 17, 2024, the Company amended the agreement with the holder of the $400,000 note, which eliminated the conversion feature and advanced the date of the loan to November 5, 2025. Interest on the notes is paid quarterly or accrues and is to be repaid at maturity along with principal, as specifically described in the notes. The Company accounted for the amendment as an extinguishment of debt and recorded a loss of $8,100 on the consolidated statements of operations for the year ended October 31, 2024. The loan incurred interest expense of $11,059 and $23,423 for the three and nine months ended July 31, 2025, respectively. The loan incurred interest expense of $7,836 and $15,672 for the three and nine months ended July 31, 2024, respectively. Accrued interest as of July 31, 2025 is $9,983, which was accrued on the unaudited condensed consolidated balance sheets within the Accounts payable and accrued expenses line item. On April 25, 2025, the Company executed a loan amendment for an extension of the maturity date of the $50,000 portion of the note payable until the earlier of the date the Company is able to achieve a listing on a national stock exchange or June 30, 2025. The terms of the amended note were not substantially different than the original and therefore did not result in an extinguishment of the original note. On July 2, 2025, the Company entered into separate Stockholder Pledge Agreement with the holder of $400,000 of the above notes with the Company's former director and Chief Technology Officer and a director and Chief Engineer to secure the Company's obligations. Pursuant to the Pledge Agreements, each Pledgor pledged 1,000,000 shares of the Company's common stock as collateral. The Pledge Agreements require the pledged shares to maintain a collateral coverage ratio equal to 400% of the outstanding principal amount of the Notes, based on a $4.00 per share valuation. If the Secured Party delivers a collateral call notice due to a decline in the value of the pledged shares or a dilution event, the Pledgors or the Company are required to provide additional shares. Failure to do so may constitute an event of default under the Notes. On September 22, 2025 the Company executed an extension of the maturity date of the $50,000 portion of the note to October 31<sup>st</sup>, 2025, with repayment of the note to occur in monthly installments from October 31<sup>st</sup> through December 31<sup>st</sup> 2025. Under the terms of the extension the note was not considered in default. The terms of the amended note were not substantially different than the original and therefore did not result in an extinguishment of the original note.

On July 31, 2024, the Company issued a convertible note payable agreement for $250,000. The convertible note matures on July 31, 2025 and carries an interest rate of 13% per annum. The principal and prior accrued interest of the note was convertible into shares of the Company's common stock at a price per share equal to a 30% discount per share of the final per-share price of a planned public offering. On October 16, 2024, the Company amended the agreement with the holder which eliminated the conversion feature, changed the interest rate to 9.75% per annum, increased the principal of the note to $500,000, and extended the maturity date of the loan to November 5, 2025. Interest on the note either is paid quarterly or accrues and is paid at maturity along with principal, as specifically described in the note. Due to the elimination of the conversion feature the Company accounted for the amendment as a significant change resulting in an extinguishment of debt and recorded a loss of $15,750 on the consolidated statements of operations for the year ended October 31, 2024. The loan incurred interest expense of $6,144 and $16,052 for the three and nine months ended July 31, 2025, respectively. Accrued interest as of July 31, 2025 and October 31, 2024 is $2,070 and $7,786, respectively, which was accrued on the unaudited condensed consolidated balance sheet within the Accounts payable and accrued expenses line item. On July 2, 2025, the Company entered into separate Stockholder Pledge Agreement with the holder of the above note with the Company's former director and executive officer and Chief Operating Officer to secure the Company's obligations. Pursuant to the Pledge Agreements, each Pledgor pledged 1,000,000 shares of the Company's common stock as collateral. The Pledge Agreements require the pledged shares to maintain a collateral coverage ratio equal to 400% of the outstanding principal amount of the Notes, based on a $4.00 per share valuation. If the Secured Party delivers a collateral call notice due to a decline in the value of the pledged shares or a dilution event, the Pledgors or the Company are required to provide additional shares. Failure to do so may constitute an event of default under the Notes.

On July 31, 2024, the Company executed a convertible note payable agreement for $250,000. The convertible note matures on May 1, 2025 and carries an interest rate of 13% per annum. The principal and prior accrued interest of the note was convertible into shares of the Company's common stock at $2.00 per share. On October 16, 2024, the Company amended the agreement with the holder which eliminated the conversion feature, changed the interest rate to 9.75% per annum, and extended the maturity date of the loan to November 5, 2025. Interest on the note either accrues or is paid quarterly or at maturity along with principal, as specifically described in the note. The Company accounted for the amendment as an extinguishment of debt and recorded a loss of $4,500 on the consolidated statements of operations for the year ended October 31, 2024. The loan incurred interest expense of $6,144 and $9,062 for the three and nine months ended July 31, 2025, respectively. Accrued interest as of July 31, 2025 and October 31, 2024 is $2,070 and $7,786, respectively, which was accrued on the unaudited condensed consolidated balance sheet as of July 31, 2025 within the Accounts payable and accrued expenses line item.

On January 9, 2025, the Company executed a note payable agreement for $50,000. The note matures on January 9, 2027 and carries an interest rate of 9.75% per annum. Interest on the note accrues and is paid at maturity along with principal, as specifically described in the note. The loan incurred interest expense of $1,229 and $1,493 for the three and nine months ended July 31, 2025, respectively. Accrued interest as of July 31, 2025 is $2,722, which was accrued on the unaudited condensed consolidated balance sheet as of July 31, 2025 within the Accounts payable and accrued expenses line item.

On February 3, 2025, the Company executed a note payable agreement for $100,000. The note matures on February 9, 2027 and carries an interest rate of 9.75% per annum. Interest on the note accrues and is paid at maturity along with principal, as specifically described in the note. The loan incurred interest expense of $2,458 and $2,330 for the three and nine months ended July 31, 2025. Accrued interest as of July 31, 2025 is $4,788, which was accrued on the unaudited condensed consolidated balance sheet as of July 31, 2025 within the Accounts payable and accrued expenses line item.

In May 19, 2025, the Company obtained a short-term loan, which totaled $250,000, from a single lender to fund operations. This loan included origination fees totaling $7,500 for net proceeds of $242,500. The loan is secured by expected (i) future cash receipts of the Company, and (ii) all other tangible and intangible personal property. Payments are expected on a weekly basis for 52 weeks. The Company is expected to repay an aggregate of $311,000 to the lender over the nominal term. The repayment amount decreases for earlier payoff dates. The loan incurred interest expense of $11,731 for the three and nine months ended July 31, 2025. Accrued interest as of July 31, 2025 is $0.

On June 8, 2025, the Company entered into a Receivables Sale Agreement pursuant to which the Company sold receivables totaling $192,000 to a third party for $150,000 from which fees of $2,000 were deducted for net proceeds of $148,000. The purchasers right to receive remittances under this agreement is contingent upon the Company's receipt of the receivables. The expected repayment is approximately $3,700 based on $3.27% of the Company estimated sales revenue. The estimated term is 1 year. The agreement is guaranteed by certain officers and directors of the Company. The loan incurred interest expense of $5,654 for the three and nine months ended July 31, 2025. Accrued interest as of July 31, 2025 is $0.

---

| | | |
|:---|:---|:---|
|  | **July 31,<br> 2025** | **October 31,<br> 2024** |
| Notes payable, current | $1681731 | $200000 |
| Notes payable, less current portion | 150000 | 1150000 |
| Total notes payable | $1831731 | $1350000 |

---

The aggregate maturity on the notes payable as of July 31, 2025, are as follows:

---

| | |
|:---|:---|
| 2025 | $200000 |
| 2026 | 1481731 |
| 2027 | 150000 |
|  | 1831731 |
| Less current portion | (1681731) |
| Notes payable, non-current portion | $150000 |

---

**NOTE 6: STOCK OPTIONS**

The 2018 Equity Incentive Plan was approved by the Board of Directors on July 1, 2018 and the Company amended the equity plan on December 17, 2023. In conjunction with the recapitalization and effective January 3, 2024, the Company adopted the Heliospace 2018 Equity Plan as the Company's Plan ("Equity Plan"). The Equity Plan limits the shares of common stock authorized to be awarded as stock awards to 2,382,352 shares as of July 31, 2025 and October 31, 2024, respectively. Employees are provided stock options vesting over a period of four years with a one-year cliff. After one year, 25% of the award size vests followed by 1/48<sup>th</sup> of the award size for each month thereafter. On a case-by-case basis, options have been granted outright with no vest period.

Due to the change-in-control transaction described in Note 1, there was a recapitalization for which the Company's stock options were adjusted for the new capital structure. The Company adjusted each of the granted options a 0.612 factor.

During the three months ended July 31, 2025 and 2024, there were no stock options granted. During the nine months ended July 31, 2025 and 2024, there were zero and 239,990 stock options granted, respectively.

The grant date fair value was calculated using the Black-Scholes option pricing model using the following weighted average inputs:

---

| | | |
|:---|:---|:---|
| Risk free interest rate | 3.9% | 3.9% |
| Expected term (years) | 6.01 | 9.95 |
| Expected volatility | 65.79% | 68.51% |
| Expected dividends | 0.0% | 0.0% |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Number of <br> Shares** | **Weighted<br> Average <br> Shares ($)** | **Weighted<br> Average<br> (Years)** | **Intrinsic<br> Value** |
| Balance as of October 31, 2023 | 2004135 | $0.08 | 7.56 | $140289 |
| Recapitalization of options | (777241) | - |  | - |
| Issued | 239990 | 0.15 | 4.15 | 1163951 |
| Canceled | - | - |  | - |
| Exercised | - | - | - | - |
| Balance as of January 31, 2024 | 1466884 | $0.09 | 4.15 | $7200270 |
| Issued | - | - |  | - |
| Canceled | (44577) | - |  | (219319) |
| Exercised | - | - | - | - |
| Balance as of April 30, 2024 | 1422307 | $0.09 | 7.52 | $6980951 |
| Issued | - | - |  | - |
| Canceled | - | - |  | - |
| Exercised | - |  |  | - |
| Balance as of July 31, 2024 | 1422307 | $0.09 | 7.27 | $6980951 |
| Balance as of October 31, 2024 | 1422307 | 0.09 | 7.02 | 6980951 |
| Issued | - | - |  | - |
| Canceled | - | - |  | - |
| Exercised | - | - | - | - |
| Balance as of January 31, 2025 | 1422307 | $0.09 | 7.02 | $6980951 |
| Issued | - | - |  | - |
| Canceled | - | - |  | - |
| Exercised | - | - | - | - |
| Balance as of April 30, 2025 | 1422307 | $0.09 | 6.52 | $6980951 |
| Issued | - | - |  | - |
| Canceled | - | - |  | - |
| Exercised | - | - | - | - |
| Balance as of July 31, 2025 | 1422307 | $0.09 | 6.27 | $6980951 |

---

Stock-based compensation from stock awards for the three months ended July 31, 2025 and 2024 was $38,849 and $56,600, respectively. Stock-based compensation from stock awards for the nine months ended July 31, 2025 and 2024 was $126,603 and $139,521, respectively. As of July 31, 2025 and 2024, there remained $145,879 and $322,171 of unrecognized stock-based compensation from stock option awards, respectively. As of July 31, 2025, there were 1,240,047 shares of common stock related to stock option grants that were vested and 182,260 stock option grants that were unvested. As of July 31, 2024, there were 1,055,871 shares of common stock related to stock option grants that were vested and 366,436 stock option grants that were unvested.

The fair value of the stock was determined using observable inputs (level 2 fair value measurement) with a market approach technique. The main input for the common stock fair value was the price of the Company's common stock as of the date of the grant.

**NOTE 7: LEASES**

The Company leases its office and manufacturing facility both classified as operating leases. The Company recognized right of use assets and lease liabilities pursuant to these leases. Leases with an initial term of 12 months or less or leases that are immaterial are not included on the unaudited condensed consolidated balance sheets. The lease liability was calculated at the commencement date of each lease by discounting the future payments using the Company's incremental borrowing rate of 10%.

In addition, the Company is a lessee under four leases with an initial term of 12 months or less. These leases combine for approximately $17,000 and $31,500 of lease expense for the three months ending July 31, 2025 and 2024, respectively. These leases combine for approximately $51,000 and $94,500 of lease expense for the nine months ending July 31, 2025 and 2024, respectively.

The lease for the manufacturing facility commenced on June 1, 2022 and has a term of five years. For the first year the monthly lease payments were $36,000. The monthly lease payments are subject to an annual increase of 3%.

The office lease commenced on September 1, 2023 and has a term of two years. The rent is fixed at $3,909 for the term of the lease.

Future minimum lease payments required under operating leases on an undiscounted cash flow basis as of July 31, 2025 were as follows:

---

| | |
|:---|:---|
| 2025 | $121922 |
| 2026 | 477956 |
| 2027 | 283626 |
| Total future minimum lease payments | $883504 |
| Less imputed interest | (79523) |
| Total operating lease liability | $803981 |

---

The Company recognized rent expense pursuant to these leases on the straight-line basis in accordance with the guidance in ASC 842. The Company recognized rent expense of $100,019 for the three months ended July 31, 2025 and 2024, and $300,057 for the nine months ended July 31, 2025 and 2024, related to these leases, which is included within facilities expense on the unaudited condensed consolidated statements of operations.

**NOTE 8: COMMITMENTS AND CONTINGENCIES**

**Legal Proceedings**

The Company is not presently a party to any legal proceedings, the resolution of which the Company believes would have a material adverse effect on its business, financial condition, operating results, or cash flows. However, legal proceedings are subject to inherent uncertainties, and an unfavorable outcome could include monetary damages, and excessive verdicts can result from litigation, and as such, could result in a material adverse impact on its business, financial position, results of operations, and/or cash flows.

**NOTE 9: INCOME TAXES**

There was no income tax expense reflected in the results of operations for the quarters ended July 31, 2025 and 2024, because the Company carried forward net losses for tax purposes.

The following table reconciles the U.S. statutory rates to the Company's effective tax rate for the quarters ended July 31, 2025 and 2024:

---

| | | |
|:---|:---|:---|
|  | **July 31,<br> 2025** | **July 31,<br> 2024** |
| Federal income taxes at statutory rate | 21.00% | 21% |
| State income taxes at statutory rate | 7.19% | 6.97% |
| Change in valuation allowance | (28.80)% | (27.95)% |
| Other | 0.61% | (0.03)% |
| Totals | - | -% |

---

Deferred tax assets as of July 31, 2025 and October 31, 2024 consist of the following components:

---

| | | |
|:---|:---|:---|
|  | **July 31,<br> 2025** | **October 31, 2024** |
| Deferred tax assets | $- | $- |
| Net operating loss carryforwards | 1180339 | 421921 |
| Capitalized research and development costs | 125303 | 100146 |
| Stock based compensation | 90398 | 54970 |
| ROU Liabilities | 224954 | - |
| Other | 210 | 210 |
| Total deferred tax asset | $1621204 | $577246 |
| Valuation allowance | (1391006) | (560134) |
| Deferred tax assets, net | $230198 | $17113 |
| Deferred tax liabilities |  |  |
| ROU Assets | (217841) | - |
| Depreciation | (12357) | (17113) |
| Net deferred tax assets | $- | $- |

---

The Company has net operating loss carry forwards available to offset future taxable income. Current tax laws limit the Company's ability to utilize these carryforwards. Because the Company's realization of the deferred tax assets is not certain, the Company fully offset the deferred tax assets resulting from these carryforwards with a valuation allowance. The Company has approximately $1,180,000 of federal and state net operating loss carrying forwards to offset future federal taxable income as of July 31, 2025.

The Company recognizes uncertain tax positions taken when filing its tax returns if it is more likely than not that the tax authorities will not uphold the position based on current tax law. As of July 31, 2025, the company has not identified any uncertain tax positions.

**NOTE 10: CLIENT CONCENTRATIONS**

Three customers accounted for 87% of the Company's outstanding receivables on July 31, 2025 and four customers accounted for 90% of the Company's outstanding receivables on October 31, 2024. The table below summarizes the accounts receivable concentrations by customer as of July 31, 2025, and October 31, 2024:

---

| | | |
|:---|:---|:---|
| | **Accounts Receivable Concentration** | **Accounts Receivable Concentration** |
| <br>**Company** | **July 31,**<br>**2025** | **October 31**<br>**2024** |
| A | 45% | 21% |
| B | 25% | 23% |
| C | 17% | 20% |
| D | 0% | 27% |
|  | 87% | 90% |

---

For the three months ended July 31, 2025 and 2024, the Company's revenue was concentrated amongst nine and eight customers, respectively. For the three months ended July 31, 2025, 94% of all revenue was obtained from government sources either as a direct contractor or subcontractor, with the remaining 6% of revenue from private customers. For the three months ended July 31, 2024, 64% of all revenue was obtained from government sources either as a direct contractor or subcontractor, with the remaining 36% of revenue from private customers.

For the nine months ended July 31, 2025 and 2024, the Company revenue was concentrated amongst eleven customers respectively. For the nine months ended July 31, 2025, 70% of all revenue was obtained from government sources either as a direct contractor or subcontractor, with the remaining 30% of revenue from private customers. For the nine months ended July 31, 2024, 75% of all revenue was obtained from government sources either as a direct contractor or subcontractor, with the remaining 25% of revenue from private customers.

**NOTE 11: SEGMENT INFORMATION**

The Company conducts its business activities and reports financial results as one business segment. The presentation of financial results as one reportable segment is consistent with the way the Company operates its business and is consistent with the manner in which the Chief Operating Decision Maker ("CODM") evaluates performance and makes resource and operating decisions for the business. The Company's CODM is the Chief Executive Officer. Furthermore, the Company notes that monitoring financial results as one reportable segment helps the CODM manage costs on a consolidated basis, consistent with the integrated nature of the operations. The CODM uses net loss, as reported on the Consolidated Statements of Operations, in evaluating the performance of the Company and determining how to allocate resources of the Company as a whole. As the CODM evaluates performance on a consolidated basis, all required financial segment information is included in the condensed consolidated financial statements.

**NOTE 12: SUBSEQUENT EVENTS**

In preparing these unaudited condensed consolidated financial statements, management has evaluated events and transactions for potential recognition or disclosure through the date the financial statements were issued. Such events or transactions are described below as of the date these unaudited condensed consolidated financial statements were issued.

The following subsequent events occurred after July 31, 2025, and prior to the filing of this Quarterly Report on Form 10-Q.

On August 26, 2025, the Company entered into a Securities Purchase Agreement with an accredited investor. Pursuant to the Purchase Agreement, the Company issued a promissory note in the aggregate principal amount of $275,000, for a purchase price of $250,000, reflecting an original issue discount of $25,000. The Note bears interest at 10% per annum and matures 12 months from the issue date.

In addition, the Company issued 25,000 unregistered shares of its common stock, nil par value (the "Commitment Shares"), to the Buyer as additional consideration. The net proceeds from the sale of the Note were approximately $200,000, after deducting legal and placement agent fees. The Company intends to use the net proceeds for general corporate and working capital purposes.

The Note is convertible, upon certain events of default or missed payments, into shares of the Company's common stock at a price equal to 90% of the lowest closing price during the 10 trading days prior to conversion, subject to adjustment. Conversions are further limited by a beneficial ownership cap of 4.99% (which the Buyer may adjust up to 9.99% with 61 days' notice).

The Note provides for monthly amortization payments beginning on February 26, 2026, with all remaining amounts due at maturity on August 26, 2026.

On September 21, 2025, Erick Frim, who had been serving as the Company's interim Chief Financial Officer and as its principal financial and accounting officer, ceased serving in such roles. Gregory Delory, the Company's Chief Executive Officer, assumed the responsibilities of principal financial and accounting officer.

On September 16, 2025 the Company issued 83,333 shares as part of a consulting agreement.

September 21, 2025 the Company executed an extension of the maturity date of the Note payable agreement dated March 12, 2024 for $150,000 until the earlier of the date the Company is able to achieve a listing on a national stock exchange or Nov 1, 2025. Under the terms of the extension the Note was not considered in default. The terms of the amended note were otherwise not substantially different than the original and therefore did not result in an extinguishment of the original note.

On September 22, 2025 the Company executed an extension of the maturity of the related party note payable agreement dated March 18, 2024 for $50,000 until the earlier of the date the Company is able to achieve a listing on a national stock exchange or October 31<sup>st</sup>, 2025. Repayment of the note is to occur in monthly installments from October 31<sup>st</sup> through December 31<sup>st</sup> 2025. The terms of the amended note were otherwise not substantially different than the original and therefore did not result in an extinguishment of the original note.

On September 22, 2025 the Company executed an extension of the maturity date of the unsecured promissory note to Indicia Capital, LLC for $150,000 to October 31<sup>st</sup>, 2025. Repayment of the note is to occur in monthly installments from October 31st through December 31st 2025 or upon investment of $1,000,000 or more. The terms of the amended note were otherwise not substantially different than the original and therefore did not result in an extinguishment of the original note.

On September 22, 2025, the Company executed an extension of the maturity date of the $50,000 portion of the note payable agreement dated June 20, 2024 to October 31<sup>st</sup>, 2025, with repayment of the note to occur in monthly installments from October 31st through December 31st 2025. The terms of the amended note were otherwise not substantially different than the original and therefore did not result in an extinguishment of the original note.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

Special Note Regarding Forward-Looking Statements

Certain matters discussed in this Quarterly Report, including (without limitation) statements under "Management's Discussion and Analysis of Financial Condition and Results of Operations" contain forward-looking statements. Although we believe that, in making any such statements, our expectations are based on reasonable assumptions, any such statement may be influenced by factors that could cause actual outcomes and results to be materially different from those projected.

These forward-looking statements include statements relating to our anticipated financial performance and business prospects, including debt reduction, currency values and financial impact, foreign exchange counterparty exposures, the impact of pending legal proceedings, adequate liquidity levels, dividends, share repurchases or other capital deployment initiatives and/or statements preceded by, followed by or that include the words "believe," "will," "will be," "will continue," "will likely result," "may," "predicts," "so we can," "when," "anticipate," "intend," "estimate," "expect," "project," "aim," "could," "plans," "seeks" and similar expressions. These forward-looking statements speak only as of the date stated, and we do not undertake any obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, even if experience or future events make it clear that any expected results expressed or implied by these forward-looking statements will not be realized. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these expectations may not prove to be correct or we may not achieve the financial results, savings or other benefits anticipated in the forward-looking statements. These forward-looking statements are necessarily estimates reflecting the best judgment of our senior management and involve a number of risks and uncertainties, some of which may be beyond our control. These risks and uncertainties, including those disclosed in the "Risk Factors" section in our registration statement on Form S-1, as amended (File No. 333-284062) (the "S-1 Registration Statement") could cause actual results to differ materially from those suggested by the forward-looking statements and include, without limitation:

● Our limited operating history makes it difficult to evaluate our future prospects and the risks and challenges we may encounter.

● Our success depends heavily on our executive officers, senior management team and highly trained employees; difficulty hiring officers and employees of equal competency or ineffective succession planning, could adversely affect our business.

● Competition could cause downward pressure on prices, fewer customer orders, reduced margins, inability to take advantage of new business opportunities, and the loss of market share.

● Our competitors may be better capitalized, have greater revenues, and have more industry or management experience.

● Our competitors may develop technologies and products that are more effective than those we develop or that render our technology and products obsolete or noncompetitive.

● Our projections of future financial results are based on a number of assumptions by our management, some or all of which may prove to be incorrect, and actual results may differ materially and adversely from such projections.

● Our estimated and projected market for our products and services may be inaccurate and may not reach our expected potential.

● We will incur significant expenses and capital expenditures to execute our business plan; there are no assurances that we will obtain adequate financing to meet these expenditures.

● We may invest significant resources in developing new products, services and technologies in pursuit of applications and revenue opportunities that may never materialize.

● Our ability to grow our business depends on our ability to develop new products, and services to satisfy changing customer demands and respond to changing industry cycles in a timely and cost-effective manner.

● Our business may be adversely affected by changes in budgetary priorities of the U.S. Government.

● Technology failures or cyber security breaches or other unauthorized access to our information technology systems or sensitive or proprietary information could have an adverse effect on the Company's business and operations.

● Federal contracting is subject to significant regulation, including rules related to bidding, billing and accounting kickbacks and false claims, and non-compliance could subject us to fines and penalties.

● Our inability to secure additional U.S. government contracts and funding may adversely affect our business, financial condition and results of operations.

● The U.S. government's budget deficit and the national debt, as well as any inability of the U.S. government to complete its budget process for any government fiscal year and consequently having to shut down or operate on funding levels equivalent to its prior fiscal year pursuant to a "continuing resolution," could have an adverse impact on our business, financial condition, results of operations and cash flows.

● Our common stock has historically experienced limited trading and you may have difficulty liquidating your shares.

● Our stock price may be volatile and purchasers of our common stock could incur substantial losses.

● We do not expect to pay dividends in the foreseeable future, and you must rely on price appreciation of your shares of common stock for return on your investment.

● Our Company's founders, directors and executive officers own or control a majority of the Company and you will have little or no management control over our business or corporate mattes.

● Our operating results may continue to be adversely affected as a result of unfavorable market, economic, social and political conditions.

We have based the forward-looking statements contained in this Quarterly Report primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, results of operations, prospects, business strategy and financial needs. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Quarterly Report. We cannot assure you that the results, events and circumstances reflected in the forward-looking statements will be achieved or occur, and actual results, events or circumstances could differ materially from those described in the forward-looking statements.

The forward-looking statements made in this Quarterly Report relate only to events as of the date on which such statements are made. We undertake no obligation to update any forward-looking statements after the date of this Quarterly Report or to conform such statements to actual results or revised expectations, except as required by law.

**Overview of Operations**

Heliospace, our wholly owned subsidiary, is an aerospace company specializing in the design, engineering, assembly and test of space flight qualified hardware, providing systems engineering, modeling, analysis, integration and test services to customers in government, commercial, private and non-profit markets. Heliospace designs, fabricates, assembles and tests space qualified hardware, including radar antennas for the NASA Europa Clipper mission, the antennas for the SunRISE CubeSat constellation, and deployable systems and sensors for numerous lunar landers and the Mars Sample Return program. Heliospace also provides systems engineering, integration and test, and mission formulation services, including support for the design, testing, and launch of the James Webb Space Telescope, formulation and design of the Roman Space Telescope, Habworlds Observatory, Mars Sample Return, and the Atmospheric Observing System.

In January 2024, via a share exchange accounted for as a reverse acquisition, Web3 Corporation, a Florida corporation that was originally incorporated under the name Stirling Bridge Group, Inc. and was a specialized small business venture lender, acquired 100% of the stock of Heliospace, and changed its name from Web3 Corporation to Helio Corporation (the "Business Combination"). Heliospace was the accounting acquirer in the Business Combination and was determined to be the sole predecessor of Helio Corporation. Accordingly, this discussion and analysis, and the financial statements included elsewhere in this quarterly report, reflect the financial condition and results of operations of Helio Corporation and its sole consolidated subsidiary, Heliospace, after the Business Combination and of Heliospace prior to the Business Combination.

Trends, Events, and Uncertainties

Government Budget Uncertainty and Proposed NASA Cuts

A significant portion of our revenue is derived from contracts with the U.S. federal government, including through NASA, where our subsidiary, Heliospace, provides mission-critical components and engineering services for science and exploration missions. Accordingly, our financial condition and results of operations are influenced by trends in federal discretionary spending, particularly in space science and technology programs.

One key emerging trend is the proposed shift in federal budget priorities under the Trump administration. In April 2025, the administration released its draft budget proposal for fiscal year 2026, which recommends a significant reduction in overall discretionary spending, including an approximately 50% cut to NASA's Science Mission Directorate. If enacted, this proposal would reduce funding for core science programs such as astrophysics, heliophysics, Earth science, and planetary science—areas directly aligned with Heliospace's technical capabilities and historical contract activity.

Although this proposal remains subject to Congressional negotiation and approval, the magnitude of the proposed cuts and the administration's stated intent to reprioritize government resources away from space science programs present a material uncertainty for our future growth. Any resulting reduction, delay, or cancellation of NASA programs could reduce the number of available contracts, increase competition for limited awards, and adversely impact our future revenue and profitability.

In addition, broader fiscal challenges at the federal level—such as the rising national debt, persistent budget deficits, and the risk of government shutdowns or extended continuing resolutions—could result in delays to contract funding or payments, reduced availability of new program opportunities, and increased uncertainty in long-term planning. These macroeconomic pressures may also negatively affect private sector customers that rely on or benefit from government-funded space and research initiatives.

As we execute our expansion plans, we have continued to increase the percentage of revenue from private and commercial sources, and are actively working to expand our offerings to defense agencies whose budgets remain a priority for the current administration and Congress. However, these plans are subject to risks and uncertainties, and there can be no assurance that they will succeed or fully offset the effects of any reduction in government spending.

***Cybersecurity Risk and Ongoing Threat Landscape***

As a government contractor and developer of advanced aerospace technology, we operate in a highly sensitive and data-driven environment. Cybersecurity risks—including ransomware attacks, data breaches, intellectual property theft, and attempted intrusions by nation-state actors—continue to increase in frequency and sophistication across our industry. Like many companies operating in the defense and aerospace sectors, we remain a potential target for both criminal and geopolitical cyber threats.

We have implemented security protocols, systems monitoring, and access controls to protect our infrastructure and proprietary information, including information related to our work with NASA and other government agencies. However, cybersecurity is an evolving threat landscape, and there can be no assurance that our efforts will prevent all attacks or unauthorized access. A successful breach could disrupt our operations, compromise confidential data, harm our reputation, result in regulatory investigations, or expose us to legal claims and financial losses.

We will continue to invest in cybersecurity tools, training, and third-party audits to strengthen our defenses, and we are evaluating compliance with emerging federal cybersecurity requirements. Nonetheless, future cybersecurity incidents could materially affect our business, financial condition, or results of operations.

Results of Operations

**Comparison of the Three Months Ended July 31, 2025 to the Three Months Ended July 31, 2024**

The following table provides certain selected financial information of Helio Corporation for the periods presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | | |
|  | **July 31,** | **July 31,** | | |
|  | **2025** | **2024** |<br>**Change** |<br>**%** |
| Revenues | $784587 | $1664193 | (879606) | (53)% |
| Costs of revenue | 686197 | 1103485 | (417288) | (38)% |
| Operating expenses | 1000284 | 910964 | 89320 | 10% |
| Operating income (loss) | (901894) | (350256) | (551638) | 157% |
| Interest expense, net | (48860) | (24430) | (24430) | 100% |
| Net income (loss) | $(950754) | $(374686) | (576068) | 154% |
| Loss per share basic and diluted | $(0.084) | $(0.03) |  |  |

---

<u>Revenue</u>

Revenue for the three months ended July 31, 2025 decreased by 53% to $784,587 from $1,664,193 for the three months ended July 31, 2024, reflecting a lower overall volume of work compared to the prior three months due to the ongoing reformulation of the NASA Mars Sample Return program, coupled with an overall downturn in NASA hardware contract awards and a delay in at least one commercial contract. For the three months ended July 31, 2025, we serviced nine customers, two of which were direct government customers, four were commercial customers and two were non/not-for-profit customers for whom we manufactured products as a subcontractor for their government customer. One commercial customer was serviced whose sources of funds were private investment. For the three months ended July 31, 2024, we serviced thirteen customers, of which two were direct government customers and seven were private foundations, and four were non/not-for-profit customers for whom we manufactured products as a subcontractor for their government customer.

<u>Cost of Revenue</u>

The 38% decrease in cost of revenue for the three months ended July 31, 2025 to $686,197 from $1,103,485 for the three months ended July 31, 2024 mainly reflected the decreased business volume described above. As a percentage of revenue, cost of sales amounted to 87% and 66% in the three months ended July 31, 2025 and 2024, respectively. Cost of sales as a percentage of revenue increased by approximately 21% due to a lower overall revenue against certain fixed costs, and billing one services contract beyond the hours originally allocated to that contract.

<u>Operating Expenses</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | | |
|  | **July 31,** | **July 31,** | | |
|  | **2025** | **2024** |<br>**Change** |<br>**%** |
| **Operating expenses** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Professional fees | $120676 | $60000 | $60676 | 101% |
| &nbsp;&nbsp;&nbsp;Personnel expenses | 116664 | 127336 | (10672) | (8)% |
| &nbsp;&nbsp;&nbsp;Facilities expense | 49722 | 115728 | (66006) | (57)% |
| &nbsp;&nbsp;&nbsp;Depreciation | 5666 | 5666 |  | 0% |
| &nbsp;&nbsp;&nbsp;Other general and administrative<sup>(1)</sup> | 707556 | 602234 | 105322 | 17% |
| &nbsp;&nbsp;&nbsp;Total | $1000284 | $910964 | $89320 | 10% |

---

(1) Including right of use asset amortization.

Overall operating expenses increased by $89,320, or 10%, to $1,000,284 for the three months ended July 31, 2025, as compared to $910,964 for the three months ended July 31, 2024, driven by professional fees incurred in connection with a public offering attempt and higher G&A expenses associated with this and R&D activities.

<u>Other Expense</u>

We have not recorded income tax expense or benefit in the three months ended July 31, 2025 and 2024 (because of our tax loss carryforwards). We had approximately $3,179,000 of net operating loss carry forwards to offset future federal taxable income as of July 31, 2025.

The NOL carry forward is subject to review and possible adjustment by the Internal Revenue Service and state tax authorities. Under the Internal Revenue Code ("IRC") Sections 382 and 383, annual use of the Company's net operating loss carryforwards and research credit carryforwards to offset taxable income and tax, respectively, may be limited based on cumulative changes in ownership. The Company has not completed an analysis to determine whether any such limitations have been triggered as of July 31, 2025. The annual limitation, if any, will be determined based on the value of the Company immediately prior to the ownership change. Subsequent ownership changes may further affect the limitation in future years.

We recorded $48,860 in interest expense in the three months ended July 31, 2025 compared to $24,430 in the three months ended July 31, 2024, reflecting our increased amount of average outstanding debt and increased rates of interest thereunder.

<u>Net Loss</u>

Our net loss for the three months ended July 31, 2025 was $950,754, compared to a net loss of $374,686 for the three months ended July 31, 2024. The change was due to the reasons discussed above.

**Comparison of the Nine Months Ended July 31, 2025 to the Nine Months Ended July 31, 2024**

The following table provides certain selected financial information of Helio Corporation for the periods presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Nine Months Ended** | **Nine Months Ended** | | |
|  | **July 31,** | **July 31,** | | |
|  | **2025** | **2024** |<br>**Change** |<br>**%** |
| Revenues | $3384423 | $5336376 | (1951953) | 37% |
| Costs of revenue | 2680940 | 3389439 | (708499) | 21% |
| Operating expenses | 3391392 | 3261177 | 130215 | 4% |
| Operating income (loss) | (2687909) | (1314240) | (1373669) | 105% |
| Interest expense, net | (197020) | (55559) | (141461) | 255% |
| Net income (loss) | $(2884929) | $(1369799) | (1515130) | 111% |
| Loss per share basic and diluted | $0.26 | $0.12 |  |  |

---

<u>Revenue</u>

Revenue for the nine months ended July 31, 2025 decreased by 37% to $3,384,423 from $5,336,376 for the nine months ended July 31, 2024, reflecting a lower overall volume of work compared to the prior nine months due to the ongoing reformulation of the NASA Mars Sample Return program, coupled with an overall downturn in NASA hardware contract awards and a delay in at least one commercial contract. For the nine months ended July 31, 2025, we serviced eleven customers, of which two were direct government customers, one was a commercial customer with private funding, five were commercial customers and three were non/not-for-profit customers for whom we manufactured products as a subcontractor for their government customer. For the nine months ended July 31, 2024, we serviced eleven customers, of which one was a direct government customer, one was a private foundation, six were commercial customers and three were non/not-for-profit customers for whom we manufactured products as a subcontractor for their government customer.

<u>Cost of Revenue</u>

The 21% decrease in cost of revenue for the nine months ended July 31, 2025 to $2,680,940 from $3,389,439 for the nine months ended July 31, 2024 mainly reflected the decreased business volume described above. As a percentage of revenue, cost of sales amounted to 79% and 64% in the nine months ended July 31, 2025 and 2024, respectively. Cost of sales as a percentage of revenue increased by approximately 16%.

Operating Expenses

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Nine Months Ended** | **Nine Months Ended** | | |
|  | **July 31,** | **July 31,** | | |
|  | **2025** | **2024** |<br>**Change** |<br>**%** |
| **Operating expenses** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Professional fees | $343495 | $206903 | $136592 | 66% |
| &nbsp;&nbsp;&nbsp;Personnel expenses | 408908 | 336727 | 72181 | 21% |
| &nbsp;&nbsp;&nbsp;Facilities expense | 249800 | 332798 | (83318) | (25)% |
| &nbsp;&nbsp;&nbsp;Depreciation | 16996 | 16996 |  | 0% |
| &nbsp;&nbsp;&nbsp;Other general and administrative<sup>(1)</sup> | 2372513 | 2367753 | 4760 | 0.20% |
| &nbsp;&nbsp;&nbsp;Total | $3391392 | $3261177 | $130215 | 4% |

---

(1) Including right of use asset amortization.

Overall operating expenses increased by $130,215, or 4%, to $3,391,392 for the nine months ended July 31, 2025, as compared to $3,261,177 for the nine months ended July 31, 2024, mainly driven by higher professional fees, reflecting higher labor costs, mainly in connection with the preparation for the Company's underwritten public offering attempt during May of 2025.

<u>Other Expense</u>

We have not recorded income tax expense or benefit in the nine months ended July 31, 2025 and 2024, because of our tax loss carry forwards. We had approximately $3,179,000 of net operating loss carry forwards to offset future federal taxable income as of July 31, 2025.

We recorded $197,020 in interest expense in the nine months ended July 31, 2025 compared to $55,559 in the nine months ended July 31, 2024, reflecting our increased amount of average outstanding debt and increased rates of interest thereunder.

<u>Net Loss</u>

Our net loss for the nine months ended July 31, 2025 was $2,884,929, compared to a net loss of $1,369,799 for the nine months ended July 31, 2024. The change was due to the reasons discussed above.

**Liquidity and Capital Resources**

As of July 31, 2025, we had cash and cash equivalents of $43,933, representing a decrease of $507,619 from $551,552 as of October 31, 2024. The decrease primarily reflects our operating losses during the period, partially offset by proceeds from the issuance of promissory notes.

Capital Resources Outlook

In May and June 2025, the Company entered into an additional note payable agreement and a Receivables Sale Agreement to obtain additional funding (see Note 5). Additional financing or capital investment will be necessary to sustain operations for one year from the issuance of these unaudited condensed consolidated financial statements.

As part of management's ongoing efforts to strengthen the Company's financial position, the Company is currently engaged in negotiations with prospective lenders regarding potential bridge financing arrangements, and potential investors for the purchase of convertible notes or equity investments. These discussions are ongoing, and there can be no assurance that the Company will enter into definitive agreements or that any such financing will be completed on favorable terms or at all.

If completed, the Company expects to use the net proceeds from investments and bridge financing to repay certain outstanding promissory notes and to support key operational initiatives. These include investments in research and development, expansion of sales, marketing, and business development activities, facility and infrastructure enhancements, manufacturing improvements, and other general corporate purposes, including working capital and upgrades to the Company's financial and contract management systems.

Over the longer term, the Company expects that it will need to raise substantial additional capital to accomplish its business plan over the next several years. There can be no assurance as to the availability, if any, or terms upon which such financing and capital might be available in the future. Failure to obtain adequate capital could require us to delay, reduce, or curtail operations, limit strategic initiatives, or impact our ability to service existing obligations.

The Company has outstanding unsecured notes to certain related parties with an aggregate outstanding principal balance of $1,163,280 as of July 31, 2025. The proceeds from these notes were used to meet working capital and cash flow management needs. The notes bear interest at between 6.5% and 11.25% per annum. $668,280 of these notes mature in the current 2025 fiscal year, and the remaining $495,000 mature in the 2026, 2027, or 2028 fiscal year.

As of July 31, 2025, the Company has outstanding debt from unrelated parties under notes payable in the aggregate principal amount of $1,831,731. These notes bear interest at 9.75% and 12.00% and mature within the next two fiscal years. Certain of these notes were initially convertible but all such convertible notes were amended to eliminate the conversion features in consideration of the issuance by the Company and/or the transfer by certain shareholders of shares of the Company's common stock. See Note 5. Interest on these notes either accrues or is paid quarterly or at maturity along with principal, as specifically described in the note. Upon the occurrence and during the continuance of any default by the Company under any of the above notes, which default is not cured within fifteen (15) days following written notice of such default from the payee, the payee may declare the entire unpaid principal and unpaid interest immediately due and payable. Certain of these notes are secured by the Company's accounts receivable, and by shares of common stock pledged by one of the Company's shareholders. In addition, certain of these notes become due, and the payees under certain of these notes have the right to accelerate their notes, upon the completion of an offering.

Because of historical and expected operating losses and net operating cash flow deficits, there is substantial doubt about the Company's ability to continue as a going concern for one year from the issuance of the unaudited condensed consolidated financial statements, which is not alleviated by management's plans. The unaudited condensed consolidated financial statements have been prepared under the going concern basis of accounting. These unaudited condensed consolidated financial statements do not include any adjustments that might be necessary from the outcome of this uncertainty.

**Cash Flows**

***Comparison of the Nine Months Ended July 31, 2025 to the Nine Months Ended July 31, 2024.***

---

| | | |
|:---|:---|:---|
|  | **Nine months Ended** | **Nine months Ended** |
|  | **July 31,** | **July 31,** |
|  | **2025** | **2024** |
| Cash provided by (used in) operating activities | $(1549753) | $(1285077) |
| Cash provided by (used in) investing activities | $- | $- |
| Cash provided by (used in) financing activities | $1042134 | $1114272 |
| Cash on hand (end of period) | $43933 | $333531 |

---

<u>Cash Flows from/used in Operating Activities</u>

For the nine months ended July 31, 2025, net cash used in operating activities was $(1,549,753), compared to cash used in operating activities of $(1,285,077) for the nine months ended July 31, 2024.

Our operating cash flow results were affected by the aging and timing of certain working capital items. During the nine months ended July 31, 2025 and 2024, our negative operating cash flow was attributed mainly to our net loss, as described above.

During the nine months ended July 31, 2025, the Company reported $(1,549,753) of cash used in operating activities. The Company's negative operating cash flow was attributed mainly to a net loss of $(2,884,929) and is partially offset by a decrease in accounts receivable of $788,869, and a decrease in work in process of $174,537.

During the nine months ended July 31, 2024, the Company reported $(1,285,077) of cash used in operating activities. The Company's negative operating cash flow was attributed mainly to a net loss of $(1,369,799), a decrease in work in process of $958,445, a decrease in accounts payable and accrued expense of $305,565, a decrease in operating lease liability of $243,655 and partially offset by a decrease in accounts receivable of $992,014 and increase in accrued compensation of $172,810.

<u>Cash Flows used in Investing Activities</u>

During the nine months ended July 31, 2025 and 2024, net cash used in investing activities was $0.

<u>Cash Flows from/used in Financing Activities</u>

During the nine months ended July 31, 2025, net cash from financing activities was $1,042,154, which included the incurrence of new debt discussed above.

During the nine months ended July 31, 2024, net cash provided by financing activities was $1,114,272, which mainly included $1,046,306 in net proceeds from incurrence of debt discussed above.

Material Cash Commitments

The Company's material future cash commitments, to be paid from cash flows from operations, are to repay its current debt obligations and payments under leases for its facilities. The Company does not have any material commitments for capital expenditures. The following table shows the material future commitments for the years ending October 31st:

---

| | | | |
|:---|:---|:---|:---|
|  | **Leases** | **Debt** | **Total** |
| Remainder of 2025 | $121922 | $785404 | $907326 |
| 2026 | 477956 | 1564607 | 2042563 |
| 2027 | 283626 | 260000 | 543626 |
| 2028 |  | 385000 | 385000 |
| 2029 |  |  |  |
| Total | $**883504** | $**2995011** | $**3878515** |

---

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements or relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities.

Critical Accounting Policies and Significant Judgments and Estimates

This discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP"). The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

While our significant accounting policies are described in more detail in the notes to our financial statements included elsewhere in this quarterly report, we believe that the following accounting policies are critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management's judgments and estimates.

We believe our most critical accounting policies and estimates relate to the following:

● Revenue Recognition

● Work in Progress

● Lease Accounting

Revenue Recognition

Revenue related to contracts with customers is evaluated utilizing the following steps: (i) Identify the contract, or contracts, with a customer; (ii) Identify the performance obligations in the contract; (iii) Determine the transaction price; (iv) Allocate the transaction price to the performance obligations in the contract; (v) Recognize revenue when the Company satisfies a performance obligation.

Revenues from cost-plus and time and materials contracts are recognized with each invoice. For fixed price contracts including purchase orders with specific priced milestone deliveries, revenue is recognized upon invoicing for each milestone completed. Revenue on fixed price contracts that are still in progress at month end are otherwise recognized on the percentage-of-completion method, measured by the percentage of total costs incurred to date to the estimated total costs for each contract. This method is used because management considers total costs to be the best available measure of progress on these contracts.

***Work in Progress***

Inventory consists of work in progress and consists of estimated revenue calculated on a percentage of completion based on direct labor and materials in relation to the total contract value. The Company does not maintain raw materials nor finished goods.

Leases

We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use ("ROU") assets, operating lease liabilities — current, and operating lease liabilities — noncurrent on the balance sheets. Finance leases are included in property and equipment, other current liabilities, and other long-term liabilities in our balance sheets.

ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we generally use our incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

Leases with a lease term of 12 months or less at inception are not recorded on our balance sheet and are expensed on a straight-line basis over the lease term in our statement of operations.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Not applicable

ITEM 4. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

As of July 31, 2025, the end of the period covered by this Quarterly Report on Form 10-Q, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended).

Based on this evaluation, management concluded that our disclosure controls and procedures were not effective as of July 31, 2025, due to the presence of material weaknesses in our internal control over financial reporting, as described below.

Identified Material Weaknesses

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company's annual or interim financial statements will not be prevented or detected on a timely basis.

Although management has not yet completed a formal evaluation of the Company's internal control over financial reporting, certain control deficiencies were identified that are significant enough to suggest the existence of material weaknesses, including:

● Lack of Segregation of Duties. The Company did not maintain adequate segregation of duties within its finance and accounting function. This deficiency increases the risk that errors or fraudulent activity could occur and remain undetected in a timely manner.

● Insufficient Accounting and Financial Reporting Expertise. The Company did not have a sufficient number of qualified personnel with the requisite knowledge of U.S. generally accepted accounting principles (GAAP) and SEC reporting requirements to ensure the timely and accurate preparation, review, and disclosure of financial statements.

**Remediation Plan**

We are actively working to remediate these material weaknesses. Planned remediation steps include hiring additional qualified accounting personnel and implementing more robust internal review and approval procedures. We will continue to monitor and assess the effectiveness of our remediation efforts in future periods.

**Changes in Internal Control over Financial Reporting**

There were no changes in our internal control over financial reporting during the fiscal quarter ended July 31, 2025, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II—OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

We are not currently party to any legal proceedings, and we are not aware of any pending or threatened litigation against us that we believe could have a material adverse effect on our business, operating results, or financial condition.

ITEM 1A. RISK FACTORS.

As a smaller reporting company, we are not required to provide the information required by this item.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

None

ITEM 4. MINE SAFETY DISCLOSURES.

Not applicable.

ITEM 5. OTHER INFORMATION.

Subsequent Events

The following subsequent events occurred after July 31, 2025, and prior to the filing of this Quarterly Report on Form 10-Q.

On August 26, 2025, the Company entered into a Securities Purchase Agreement with an accredited investor. Pursuant to the Purchase Agreement, the Company issued a promissory note in the aggregate principal amount of $275,000, for a purchase price of $250,000, reflecting an original issue discount of $25,000. The Note bears interest at 10% per annum and matures 12 months from the issue date.

In addition, the Company issued 25,000 unregistered shares of its common stock, nil par value (the "Commitment Shares"), to the Buyer as additional consideration. The net proceeds from the sale of the Note were approximately $200,000, after deducting legal and placement agent fees. The Company intends to use the net proceeds for general corporate and working capital purposes.

The Note is convertible, upon certain events of default or missed payments, into shares of the Company's common stock at a price equal to 90% of the lowest closing price during the 10 trading days prior to conversion, subject to adjustment. Conversions are further limited by a beneficial ownership cap of 4.99% (which the Buyer may adjust up to 9.99% with 61 days' notice).

The Note provides for monthly amortization payments beginning on February 26, 2026, with all remaining amounts due at maturity on August 26, 2026.

On September 21, 2025, Erick Frim, who had been serving as the Company's interim Chief Financial Officer and as its principal financial and accounting officer, ceased serving in such roles. Gregory Delory, the Company's Chief Executive Officer, assumed the responsibilities of principal financial and accounting officer.

On September 16, 2025 the Company issued 83,333 shares as part of a consulting agreement.

On September 21, 2025 the Company executed an extension of the maturity date for the Note payable agreement dated March 12, 2024 for $150,000 until the earlier of the date the Company is able to achieve a listing on a national stock exchange or Nov 1, 2025. Under the terms of the extension the Note was not considered in default. The terms of the amended note were not substantially different than the original and therefore did not result in an extinguishment of the original note.

On September 22, 2025 the Company executed an extension of the maturity of the related party note payable agreement dated March 18, 2024 for $50,000 until the earlier of the date the Company is able to achieve a listing on a national stock exchange or October 31<sup>st</sup>, 2025. Repayment of the note will occur in monthly installments from October 31<sup>st</sup> through December 31<sup>st</sup> 2025. Under the terms of the extension the note was not considered in default. The terms of the amended note were not substantially different than the original and therefore did not result in an extinguishment of the original note.

On September 22, 2025 the Company executed an extension of the maturity date of the unsecured promissory note to Indicia Capital, LLC for $150,000 to October 31<sup>st</sup>, 2025. Repayment of the note to occur in monthly installments from October 31st through December 31st 2025 or upon investment of $1,000,000 or more. Under the terms of the extension the note was not considered in default. The terms of the amended note were not substantially different than the original and therefore did not result in an extinguishment of the original note.

On September 22, 2025, the Company executed an extension of the maturity date of the $50,000 portion of the note payable agreement dated June 20, 2024 to October 31<sup>st</sup>, 2025, with repayment of the note to occur in monthly installments from October 31st through December 31st 2025. Under the terms of the extension the note was not considered in default. The terms of the amended note were not substantially different than the original and therefore did not result in an extinguishment of the original note.

ITEM 6. EXHIBITS.

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 10.1\* | [Note Amendment dated September 22, 2025, for Promissory Note issued to M. David Shapiro on March 18, 2024, as amended, in the principal amount of $50,000, bearing interest at 9.75% per annum.](ea025816201ex10-1_helio.htm) |
| 10.2\* | [Note Amendment dated September 21, 2025, for Promissory Note issued to Scott Nealey on March 12, 2024, as amended, in the principal amount of $150,000, bearing interest at 9.75% per annum](ea025816201ex10-2_helio.htm) |
| 10.3\* | [Note Amendment dated September 22, 2025 for Promissory Note issued to Indicia Capital, LLC dated April 16, 2025](ea025816201ex10-3_helio.htm) |
| 10.4\* | [Note Amendment dated September 22, 2025, for Promissory Note issued to James Byrd on March 18, 2024, in the principal amount of $50,000,bearing interest at 9.75% per annum](ea025816201ex10-4_helio.htm) |
| 10.5 | [Securities Purchase Agreement, dated August 26, 2025, by and between Helio Corporation and the Buyer (previously filed as Exhibit 10.1 to the registrant's form 8-K dated September 2, 2025)](https://www.sec.gov/Archives/edgar/data/1953988/000121390025083484/ea025561001ex10-1_helio.htm) |
| 10.6 | [$275,000 Promissory Note, dated August 26, 2025, issued by Helio Corporation (previously filed as Exhibit 10.2 to the registrant's form 8-K dated September 2, 2025)](https://www.sec.gov/Archives/edgar/data/1953988/000121390025083484/ea025561001ex10-2_helio.htm) |
| 31.1\* | [Certification of Principal Executive Officer and Principal Financial and Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ea025816201ex31-1_helio.htm) |
| 32.1\* | [Certification of Principal Executive Officer and Principal Financial and Accounting Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ea025816201ex32-1_helio.htm) |
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |

---

\* Filed herein

The XBRL related information in Exhibit 101 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | HELIO CORPORATION | HELIO CORPORATION |
| Date: September 22, 2025 | By: | /s/ Gregory T. Delory |
|  |  | Gregory T. Delory |
|  |  | Chief Executive Officer and<br> Chairman of the Board of Directors |
|  |  | (Principal Executive Officer and Principal Financial and Accounting Officer) |

---

## Exhibit 10.1

**Exhibit 10.1**

<u>LOAN EXTENSION AGREEMENT</u>

This Agreement is entered into on September 22, 2025, by and between Helio Corporation ("Helio") and David Shapiro "(Lender).

&nbsp;&nbsp;&nbsp;&nbsp;1. Helio owes Lender the sum of $50,000 (the "Loan"), plus accrued at the base rate of 9.75%
per annum.

&nbsp;&nbsp;&nbsp;&nbsp;2. The Loan was due on June 30, 2025 and has not been paid. Lender elected and hereby agrees not to declare
a default under the Loan subject to the provisions hereof.

&nbsp;&nbsp;&nbsp;&nbsp;3. The Loan maturity date is hereby extended to October 31, 2025. Interest shall remain at 9.75% per annum,
accrued since inception of the Loan, however, in the event the Loan is not paid on a timely basis as set forth herein, interest at 18%
per annum shall be deemed to have begun accruing from July 1, 2025 forward and shall be due and payable at maturity.

&nbsp;&nbsp;&nbsp;&nbsp;4. Principal payments shall be due and payable, along with accrued interest, as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) 33.33% of the Principal amount of the Loan, along with accrued interest thereon shall be due on or before
October 31, 2025;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) 33.33% of the Principal amount of the Loan, along with accrued interest thereon, shall be due and payable
on or before November 30, 2025; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) All remaining Principal and accrued interest shall be due and payable on or before December 31, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;5. Provided that all payments are made in a timely manner, time being of the essence, Lender agrees to
waive the higher interest rate herein and collect only the base contract rate of interest of 9.75% per annum.

&nbsp;&nbsp;&nbsp;&nbsp;6. All other terms and conditions of the Loan shall remain in full force and effect.

---

| | | | |
|:---|:---|:---|:---|
| Helio Corporation | Helio Corporation | David Shapiro | David Shapiro |
| By: | /s/ Greg Delory | By: | /s/ David Shapiro |
| Greg Delory, President and CEO | Greg Delory, President and CEO | David Shapiro | David Shapiro |

---

## Exhibit 10.2

**Exhibit 10.2**

<u>Extension to Promissory Note Maturity</u>

This is an Amendment to that certain Promissory Note in the amount of One Hundred Fifty Thousand Dollars ($150,000) hereinafter referred to as (the "Note") dated March 12, 2024 by and between Helio Corporation ("Maker") and Scott Nealey ("Payee").

&nbsp;&nbsp;&nbsp;&nbsp;1. The Maker and Payee hereby Amend the Note to provide that the Note, including all principal and accrued
interest, will be paid in full by Maker at the *earlier* of: (i) such time as Maker is able to achieve a listing on a national stock
exchange (NYSE or Nasdaq); or (ii) Nov 1 , 2025.

&nbsp;&nbsp;&nbsp;&nbsp;2. The note is not considered in default as of July 31st, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Other than as specifically amended hereby, all other terms and provisions of the Note dated March 12,
2024 remain in full force and effect.

---

| | | |
|:---|:---|:---|
| By: | /s/ Greg Delory | /s/ Scott Nealey |
|  | Greg Delory, CEO | Scott Nealey |

---

## Exhibit 10.3

**Exhibit 10.3**

<u>LOAN EXTENSION AGREEMENT</u>

This Agreement is entered into on September 22, 2025, by and between Helio Corporation ("Helio") and Indicia Capital, LLC "(Lender).

&nbsp;&nbsp;&nbsp;&nbsp;1. Helio owes Lender the sum of $150,000 (the "Loan"), plus accrued at the base rate of 9.75%
per annum.

&nbsp;&nbsp;&nbsp;&nbsp;2. The Loan was due on June 30, 2025 and has not been paid. Lender elected and hereby agrees not to declare
a default under the Loan subject to the provisions hereof.

&nbsp;&nbsp;&nbsp;&nbsp;3. The Loan maturity date is hereby extended to October 31, 2025. Interest shall remain at 9.75% per annum,
accrued since inception of the Loan, however, in the event the Loan is not paid on a timely basis as set forth herein, interest at 18%
per annum shall be deemed to have begun accruing from July 1, 2025 forward and shall be due and payable at maturity.

&nbsp;&nbsp;&nbsp;&nbsp;4. Principal payments shall be due and payable, along with accrued interest, as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) 33.33% of the Principal amount of the Loan, along with accrued interest thereon shall be due on or before
October 31, 2025;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) 33.33% of the Principal amount of the Loan, along with accrued interest thereon, shall be due and payable
on or before November 30, 2025; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) All remaining Principal and accrued interest shall be due and payable on or before December 31, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;5. Provided that all payments are made in a timely manner, time being of the essence, Lender agrees to
waive the higher interest rate herein and collect only the base contract rate of interest of 9.75% per annum.

&nbsp;&nbsp;&nbsp;&nbsp;6. All other terms and conditions of the Loan shall remain in full force and effect.

---

| | | | |
|:---|:---|:---|:---|
| Helio Corporation | Helio Corporation | Indicia Capital, LLC | Indicia Capital, LLC |
| By: | /s/ Greg Delory | By: | /s/ James Byrd |
| Greg Delory, President and CEO | Greg Delory, President and CEO | James Byrd, Manager | James Byrd, Manager |

---

## Exhibit 10.4

**Exhibit 10.4**

<u>LOAN EXTENSION AGREEMENT</u>

This Agreement is entered into on September 22, 2025, by and between Helio Corporation ("Helio") and James S. Byrd, SEP-IRA "(Lender).

&nbsp;&nbsp;&nbsp;&nbsp;1. Helio owes Lender the sum of $50,000 (the "Loan"), plus accrued at the base rate of 9.75%
per annum.

&nbsp;&nbsp;&nbsp;&nbsp;2. The Loan was due on June 30, 2025 and has not been paid. Lender elected and hereby agrees not to declare
a default under the Loan subject to the provisions hereof.

&nbsp;&nbsp;&nbsp;&nbsp;3. The Loan maturity date is hereby extended to October 31, 2025. Interest shall remain at 9.75% per annum,
accrued since inception of the Loan, however, in the event the Loan is not paid on a timely basis as set forth herein, interest at 18%
per annum shall be deemed to have begun accruing from July 1, 2025 forward and shall be due and payable at maturity.

&nbsp;&nbsp;&nbsp;&nbsp;4. Principal payments shall be due and payable, along with accrued interest, as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) 33.33% of the Principal amount of the Loan, along with accrued interest thereon shall be due on or before
October 31, 2025;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) 33.33% of the Principal amount of the Loan, along with accrued interest thereon, shall be due and payable
on or before November 30, 2025; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) All remaining Principal and accrued interest shall be due and payable on or before December 31, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;5. Provided that all payments are made in a timely manner, time being of the essence, Lender agrees to
waive the higher interest rate herein and collect only the base contract rate of interest of 9.75% per annum.

&nbsp;&nbsp;&nbsp;&nbsp;6. All other terms and conditions of the Loan shall remain in full force and effect.

---

| | | | |
|:---|:---|:---|:---|
| Helio Corporation | Helio Corporation | James S Byrd SEP-IRA | James S Byrd SEP-IRA |
| By: | <u>/s/</u> Greg Delory | By: | /s/ James Byrd |
| Greg Delory, President and CEO | Greg Delory, President and CEO | James Byrd | James Byrd |

---

## Exhibit 31.1

**Exhibit 31.1**

**Certification of Principal Executive Officer and Principal Financials and Accounting Officer<br> Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002**

I, Gregory T. Delory, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Helio Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: September 22, 2025 | /s/ Gregory T. Delory | /s/ Gregory T. Delory |
|  | Name: | Gregory T. Delory |
|  | Title: | Chief Executive Officer |
|  |  | (Principal Executive Officer and Principal Financial and Accounting Officer) |

---

## Exhibit 32.1

**Exhibit 32.1**

**Certification of Principal Executive Officer and Principal Financial and Accounting Officer<br> Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Gregory T. Delory, the Chief Executive Officer of Helio Corporation (the "Company"), hereby certify, that, to my knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;1. The
Quarterly Report on Form 10-Q for the period ended July 31, 2025 (the "Report") of the Company fully complies with the requirements
of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;2. The
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
Company.

---

| | | |
|:---|:---|:---|
| Date: September 22, 2025 | /s/ Gregory T. Delory | /s/ Gregory T. Delory |
|  | Name: | Gregory T. Delory |
|  | Title: | Chief Executive Officer |
|  |  | (Principal Executive Officer and Principal Financial and Accounting Officer) |

---